Clinical Trials Browser

Phase 1/2 × Unknown × Breast × Clear all

NCT05830097 2024-08-26

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

BreastGastrointestinalThoracic

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT04469127 2024-04-10

Heroine01

Phase 1/2 Unknown

Breast Neoplasms

NCT06328387 2024-03-25

HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer

Phase 1/2 Unknown

Breast Neoplasms

NCT05033925 2024-02-28

Ficus Septica Leaves Fraction as a Complementary Therapy for Stadium IV Breast Cancer Patients

Phase 1/2 Unknown

Breast Neoplasms, Neoplasms

NCT05574881 2024-02-26

Dalpiciclib, Fulvestrant, Trastuzumab and Pertuzumab in HR Positive, HER2 Positive Metastatic Breast Cancer

Phase 1/2 Unknown

Breast Neoplasms

NCT05575804 2024-02-26

GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer

Phase 1/2 Unknown

Advanced/ Metastatic Her-2 Positive Breast Cancer

NCT05464173 2024-01-22

CINDERELLA

Phase 1/2 Unknown

Breast Neoplasms

NCT03382340 2023-09-28

IMX-110 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms

NCT05845138 2023-08-01

A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression.

Phase 1/2 Unknown

Breast Neoplasms

NCT05708950 2023-07-13

A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

Phase 1/2 Unknown

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Uterine Neoplasms

NCT05927779 2023-07-03

Study of TFX06 in Women With Advanced Breast Cancer.

Phase 1/2 Unknown

Breast Neoplasms

NCT05928780 2023-07-03

An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC in First-line Treatment (FUTURE-Trop2)

Phase 1/2 Unknown

Triple Negative Breast Neoplasms

NCT04348643 2023-04-18

Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer

Phase 1/2 Unknown

BreastGastrointestinalThoracic

Breast Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT05335473 2023-04-06

Iribrine Plus Tucidinostat in the Treatment of HR+/HER2 Advanced Breast Cancer After CDK4/6 Inhibitor Failure

Phase 1/2 Unknown

HR Positive HER2 Negative Advanced Breast Cancer

NCT05746728 2023-04-06

Surufatinib Combined With Tislelizumab in the Second-line and Further Treatment of Triple-negative Breast Cancer

Phase 1/2 Unknown

Triple Negative Breast Neoplasms

NCT05792410 2023-03-31

A Phase Ⅰb/Ⅱ Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or Metastatic Breast Cancer.

Phase 1/2 Unknown

Breast Neoplasms

NCT05775575 2023-03-20

A Clinical Trial of TQB3909 Tablets in Patients With Breast Cancer

Phase 1/2 Unknown

Advanced Breast Cancer

NCT03772353 2023-03-07

PLEASURABLE

Phase 1/2 Unknown

Breast Neoplasms

NCT03475953 2023-03-03

REGOMUNE

Phase 1/2 Unknown

BreastEndocrineGastrointestinalGenitourinaryHead & NeckNETOther solid neoplasmSarcomaThoracic

Gastro-enteropancreatic neuroendocrine tumor, Turcot syndrome, Tertiary Lymphoid Structures, Mesothelioma, Malignant, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Neoplasm Metastasis, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Triple Negative Breast Neoplasms

NCT05747313 2023-02-28

Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast Cancer

Phase 1/2 Unknown

Breast Neoplasms

NCT02983071 2023-02-15

G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer

Phase 1/2 Unknown

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT04582968 2023-01-18

Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases

Phase 1/2 Unknown

Brain Neoplasms, Breast Neoplasms

NCT05622227 2022-11-18

68Ga PET/CT Imaging in Breast Cancer Patients

Phase 1/2 Unknown

Breast Neoplasms

NCT05602792 2022-11-02

A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

BreastGastrointestinalHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Esophageal Neoplasms, Sarcoma

NCT03805399 2022-08-10

FUTURE

Phase 1/2 Unknown

Triple Negative Breast Neoplasms

NCT03913234 2022-05-10

Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients

Phase 1/2 Unknown

Breast Neoplasms

NCT04609215 2022-04-20

ImmunoBreast - A Phase Ib Study

Phase 1/2 Unknown

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04004910 2022-03-24

A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer Patients

Phase 1/2 Unknown

Breast Neoplasms

NCT04669587 2022-03-22

ENZENO

Phase 1/2 Unknown

Breast Neoplasms

NCT02630368 2022-02-02

METROmaJX

Phase 1/2 Unknown

Breast Neoplasms, Sarcoma

NCT05103917 2021-11-02

A Study to Assess the Safety, Tolerability and Antitumor Activity of X4P-001 in Combination With TNBC

Phase 1/2 Unknown

Triple Negative Breast Neoplasms

NCT04061863 2021-09-08

KORNELIA

Phase 1/2 Unknown

Breast Neoplasms

NCT04170595 2021-03-03

Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody for Injection

Phase 1/2 Unknown

HER2-positive Breast Cancer

NCT04750382 2021-02-11

A Study of HX008 for the Treatment of Patients With Metastatic Triple Negative Breast Cancer

Phase 1/2 Unknown

Triple Negative Breast Neoplasms

NCT04488107 2020-07-27

Safety, Tolerability, Pharmacokinetics and Antitumor Activity of FCN-437c

Phase 1/2 Unknown

Breast Neoplasms

NCT04430595 2020-06-12

Multi-4SCAR-T Therapy Targeting Breast Cancer

Phase 1/2 Unknown

Breast Neoplasms

NCT04427449 2020-06-11

4SCAR-CD44v6 T Cell Therapy Targeting Cancer

Phase 1/2 Unknown

BreastGastrointestinalLymphoid

Breast Neoplasms, Lymphoma, Stomach Neoplasms

NCT04073680 2020-05-21

A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

BreastGastrointestinalGynecologicHead & NeckThoracic

Breast Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Endometrial Neoplasms

NCT04355520 2020-04-21

A Study of TQ-B3525 Tablets Combined With Fulvestrant Injection in Subjects With HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer

Phase 1/2 Unknown

HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer

NCT02583542 2020-02-25

TORCMEK

Phase 1/2 Unknown

Triple Negative Breast Neoplasms

NCT03994107 2020-01-22

Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast Cancer

Phase 1/2 Unknown

Breast Neoplasms

NCT04213898 2019-12-30

SHR-1210 Combined With Albumin-bound Paclitaxel and Epirubicin Neoadjuvant for Triple Negative Breast Cancer

Phase 1/2 Unknown

Triple Negative Breast Neoplasms

NCT04152057 2019-11-05

Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer

Phase 1/2 Unknown

Breast Neoplasms

NCT03881878 2019-03-21

TAHP for Patients With HER2-positive Early Breast Cancer and Subsequent AHP Adjuvant tHerapy After Surgery

Phase 1/2 Unknown

HER2-positive Breast Cancer

NCT03518268 2019-01-17

Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor

Phase 1/2 Unknown

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

NCT03634501 2019-01-11

Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells

Phase 1/2 Unknown

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms

NCT02511301 2019-01-03

Circadian Thermal Sensing to Detect Breast Disease

Phase 1/2 Unknown

Breast Neoplasms

NCT02422199 2018-07-09

A Study of Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+Metastatic Breast Cancer Who Have Prior Received Anthracyclin, Taxane or Trastuzumab

Phase 1/2 Unknown

HER2 Positive Metastatic Breast Cancer

NCT03175341 2018-06-27

Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer

Phase 1/2 Unknown

Breast Neoplasms

NCT03238144 2017-08-03

Tissue Stresses of Cancer (Force Horizon 2020)

Phase 1/2 Unknown

Breast Cancer Female